how does tirzepatide treat sleep apnea Zepbound for Apnea: What Chicago Patients Should Know Eli Lilly Gets FDA Approval

Tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for weight management, is a dual GIP and GLP-1 receptor agonist that affects how your body regulates blood sugar and processes food

Telehealth is often included as an in-network benefit

Join the waitlist to be notified when it launches

Wegovy's cardiovascular indication rests on a large outcomes trial described in its label, in which 8,803 patients were exposed to Wegovy for a median of 37.3 months and 8,801 to placebo for a median of 38.6 months, with a primary endpoint of time to first cardiovascular death, nonfatal myocardial infarction or nonfatal stroke

Regular Check-ups: Visit your healthcare provider for regular check-ups and screenings to monitor your liver health